| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/12/2006 | EP1679075A1 Transdermal preparations and method for relieving side effects in pergolide therapy |
| 07/12/2006 | EP1679065A1 Controlled release compositions for interferon based on PEGT/PBT block copolymers |
| 07/12/2006 | EP1679064A2 Pharmaceutical compositions containing rapamycin derivatives |
| 07/12/2006 | EP1679063A1 Novel liquid preparation composition |
| 07/12/2006 | EP1678211A2 Sulfoalkyl ether-alkyl ether cyclodextrin derivatives |
| 07/12/2006 | EP1677840A1 Methods of inhibiting the adherence of lenses to their packaging materials |
| 07/12/2006 | EP1677830A2 Antagonists of the bradykinin b1 receptor |
| 07/12/2006 | EP1677829A1 Fibrinogen targetting microparticles for promoting haemostasis |
| 07/12/2006 | EP1677828A1 Composite material comprising a porous semiconductor impregnated with an organic substance |
| 07/12/2006 | EP1677826A2 Conjugate of a photosensitiser and a bacteriophage |
| 07/12/2006 | EP1677818A1 Stable aqueous g-csf-containing compositions |
| 07/12/2006 | EP1677813A1 Angiogenic peptides and uses thereof |
| 07/12/2006 | EP1677811A1 Medicament on the basis of honey, preparation and use thereof |
| 07/12/2006 | EP1677781A1 Salts of pharmacologically active compounds |
| 07/12/2006 | EP1677777A1 Pellets containing venlafaxine hydrochloride |
| 07/12/2006 | EP1677762A1 A controlled-release composition for topical application and a method of delivering an active agent to a substrate |
| 07/12/2006 | EP1677759A1 Compositions and dosage forms for enhanced absorption of gabapentin and pregabalin |
| 07/12/2006 | EP1677758A1 Compositions and dosage forms for enhanced absorption of 3-amino-n-butyl-phosphinic acid |
| 07/12/2006 | EP1677757A2 Compositions and dosage forms for enhanced absorption |
| 07/12/2006 | EP1677756A2 Administration of levodopa and carbidopa |
| 07/12/2006 | EP1677755A2 Spill resistant formulations containing clays |
| 07/12/2006 | EP1677687A2 Delivery of polymer conjugates of therapeutic peptides and proteins via coated microporjections |
| 07/12/2006 | EP1677597A2 Pharmaceutical formulations, methods and dosing regimens for the treatment and prevention of acute coronary syndromes |
| 07/12/2006 | EP1504046B1 Tri-block polymers for nanosphere-based drug or gene delivery |
| 07/12/2006 | EP1467750B1 Orodispersible pharmaceutical composition comprising perindopril |
| 07/12/2006 | EP1389212B1 3,7-diazabicyclo 3.3.1| formulations as anti-arrythmic compounds |
| 07/12/2006 | EP1071764B1 Antisense oligonucleotides for the inhibition of integrin alphav-subunit expression |
| 07/12/2006 | EP1052977A4 Treatment of chronic inflammatory disorders of the gastrointestinal tract |
| 07/12/2006 | EP1037929B1 Non-aqueous, heterogeneous polymerization process and reaction product obtained thereby |
| 07/12/2006 | EP1025846B1 Aqueous liquid preparations |
| 07/12/2006 | EP0971743B1 Stabilized medicaments containing cysteinyl derivatives |
| 07/12/2006 | EP0970114B1 Neoglycoproteins |
| 07/12/2006 | CN1802179A Compositions containing piperacillin and tazobactam useful for injection |
| 07/12/2006 | CN1802171A Stable, aqueous solution of human erythropoietin, not containing serum albumin |
| 07/12/2006 | CN1802170A Therapies for chronic inflammatory demyelinating polyneuropathy using interferon-beta |
| 07/12/2006 | CN1802158A Pharmaceutical compositions for nasal delivery |
| 07/12/2006 | CN1802152A Improved treatment of cancer with glutamine |
| 07/12/2006 | CN1802147A Ophthalmic compositions containing a synergistic combination of two polymers |
| 07/12/2006 | CN1800408A Nucleic acid transferring vector and transferring system and uses |
| 07/12/2006 | CN1800325A Marigold lutein supercritical CO2 extraction method |
| 07/12/2006 | CN1800238A Aliphatic polyester-polyamino acids copolymer with biological function and its synthesis method |
| 07/12/2006 | CN1799630A Chitosan-immune RNA composite formulation and preparation method thereof |
| 07/12/2006 | CN1799549A Process for preparing soybean isoflavone phospholipid composition |
| 07/12/2006 | CN1799548A Soybean isoflavone phospholipid composition and preparation method thereof |
| 07/12/2006 | CN1799542A Hawthorn fruit total flavone phospholipid composition and its preparation method |
| 07/12/2006 | CN1799539A Compound glutamine granules and preparation method thereof |
| 07/12/2006 | CN1263852C Extracellular matrix signalling molecules |
| 07/12/2006 | CN1263760C Novel buprenorphine ester derivatives and process for preparing the same and medical composition with long-acting analgesic effect |
| 07/12/2006 | CN1263736C Solution of tetrahydrate N-[ortho-(para-trimethyl acetoxyl benzenesulfonamide) benzoyl] glycine monosodium salt and its medicine |
| 07/12/2006 | CN1263730C Esters of L-carnitine or alkanoyl L-carnitines used as cation lipid for intracellular release pharmacological activity compound |
| 07/12/2006 | CN1263516C Medicine preparations for diagnosing helicobacter pyloni infection |
| 07/12/2006 | CN1263513C Emulsifying agent for preparing milky white cod liver oil |
| 07/12/2006 | CN1263510C Polysaccharide protein conjugate or oligosaccharide-protein conjugate, preparation method and application thereof |
| 07/12/2006 | CN1263509C Novel compositions |
| 07/12/2006 | CN1263508C Stabilizers for live vaccines |
| 07/12/2006 | CN1263478C Shuangdan extracts and its injection for treating coronary disease and angina pectoris and preparation thereof |
| 07/12/2006 | CN1263474C A topical anti-itch formulation and process for preparation thereof |
| 07/12/2006 | CN1263466C Transfusing agent of active carbon and its preparation and application in preparing cancer-treating medicine |
| 07/12/2006 | CN1263464C Cathartic |
| 07/12/2006 | CN1263463C Improved ophthalmic and contact lens solutions with a peroxide source and a cationic polymeric preservative |
| 07/12/2006 | CN1263451C Cinrofloxacin eye preparation formula and its using method |
| 07/12/2006 | CN1263447C Stable solution of reduced coenzyme Q |
| 07/12/2006 | CN1263446C Self emulsifying lipid matrix (SELM) |
| 07/12/2006 | CN1263442C Hair growth stimulant compositions with sustained action |
| 07/12/2006 | CN1263435C Liquid polymeric compositions for controlled release of bioactive substances |
| 07/11/2006 | USRE39181 1 mg/ml risperidone or salt, 7.5 mg/ml tartaric acid and sufficient sodium hydroxide buffer to adjust the pH in the range from 3 to 4; and water q.s. ad 1 ml.; suitable for oral adminstration; improved physiochemical stability |
| 07/11/2006 | US7074835 Anticancer agents |
| 07/11/2006 | US7074827 Method for treating ocular hypertension and glaucoma |
| 07/11/2006 | US7074824 Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same |
| 07/11/2006 | US7074807 Compositions and methods for inducing cell death |
| 07/11/2006 | US7074769 Antisense oligonucleotide or analog thereof comprising 10 or more contiguous bases or base analogs; for treating cancer |
| 07/11/2006 | US7074767 Preparation of a therapeutic composition |
| 07/11/2006 | US7074763 Stable formulations of nerve growth factor |
| 07/11/2006 | US7074760 Bactericides; peptide antibiotics |
| 07/11/2006 | US7074759 Treatment of case-ready food products with immobilized lactoferrin (Im-LF) and the products so produced |
| 07/11/2006 | US7074580 obtaining a sequence-defined molecular weight markers that provide an accurate and robust calibration set for determinations of molecular weight of production batches; subjecting the molecular weight markers to column chromatography to establish a relationship between retention time and molecular weight |
| 07/11/2006 | US7074575 Anticancer activity of IL- 19 polypeptide molecules. IL-19 is a cytokine involved in inflammatory processes and human disease. The present invention includes Use of IL-19 for decreasing proliferation of ovarian cancer cells for ovarian |
| 07/11/2006 | US7074574 Method of detecting growth differentiation factor-7 (GDF-7) using GDF-7 antibodies |
| 07/11/2006 | US7074438 Compositions for oral delivery of nutrients and pharmaceuticals |
| 07/11/2006 | US7074436 Method for the production of phyllanthus extracts |
| 07/11/2006 | US7074432 Drug , biocompatible polymer and biphosphonate compound |
| 07/11/2006 | US7074431 Expanding the homogeneous solution by exposing it to a change in pressure under conditions such that the solution or homogeneous dispersion does not boil |
| 07/11/2006 | US7074430 Oral administering |
| 07/11/2006 | US7074429 Using stearic acid or zinc stearate as lubricant |
| 07/11/2006 | US7074427 Comprises a shell with a gas enclosed in the internal space thereof as well as a substance capable of generating active oxygen species upon irradiation of the shell with an ultrasound as retained or contained in shell; therapy |
| 07/11/2006 | US7074424 Polyalkylene glycol viscosity-enhancing polymeric formulations |
| 07/11/2006 | US7074423 Osmotic delivery system with early zero order push power engine |
| 07/11/2006 | US7074419 Cosmetic and pharmaceutical oil in water emulsion comprising polyether modified polysiloxanes |
| 07/11/2006 | US7074418 Conjugated fatty acid based emulsion and methods for preparing and using same |
| 07/11/2006 | US7074417 At least three delayed release dosages forms, each of which has a different release profile, with the Cmax for the antiviral product being reached in less than about twelve hours. |
| 07/11/2006 | US7074412 For therapy of orthopaedic and dental, including periodontal, diseases |
| 07/11/2006 | US7074405 antibody binds target tissue and conjugate carrying epitope (haptens) |
| 07/11/2006 | US7074403 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 07/11/2006 | US7074395 Mixture of alcohol and quaternary ammonium compound; hair setting |
| 07/11/2006 | US7074392 for high penetration into fingernails and toenails; contains humectant for trapping water and liquid nail lacquer containing film forming agent |
| 07/11/2006 | US7074389 For therapy and prophylaxis, side effect reduction |
| 07/11/2006 | US7074386 Contacting a microporous material with a hydrostatic fluid having at least one specified material carried therein, under pressure which structurally distorts the lattice sufficiently to permit entry of the at least one specified material |
| 07/11/2006 | CA2355102C Antiparasitic formulations comprising doramectin |
| 07/11/2006 | CA2341375C Extended release buccal bioadhesive tablet |
| 07/11/2006 | CA2309172C Aminobiguanides to disinfect contact lenses and preserve pharmaceutical compositions |